U.S. Pharmaceuticals & Biotech Most Popular Stocks

Virpax Pharmaceuticals

Market Cap: US$31.2k

A preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders.

Blue Water Ventures International

Market Cap: US$30.3k

Through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments.

China Medicine

Market Cap: US$28.7k

Produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China.

T2 Biosystems

Market Cap: US$28.0k

Engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare.

Curative Biosciences

Market Cap: US$25.8k

Focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol.

Australis Capital

Market Cap: US$25.4k

Operates as a cannabis company.

Petlife Pharmaceuticals

Market Cap: US$22.2k

Engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States.

Telesis Bio

Market Cap: US$22.2k

A synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.

Marijuana Company of America

Market Cap: US$22.1k

Develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States.

Dragon Life Science Holdings Group

Market Cap: US$20.0k

Operates as regional Internet service provider.

EVIO

Market Cap: US$19.2k

Provides analytical testing and consulting services for cannabis and hemp industry.

Veritas Farms

Market Cap: US$16.3k

Focuses on growing, producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids.

NanoLogix

Market Cap: US$16.3k

A biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms.

Bioasis Technologies

Market Cap: US$15.9k

A development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.

Regenicin

Market Cap: US$15.3k

Focuses on developing and commercializing a technology of tissue-engineered skin substitutes.

Aeolus Pharmaceuticals

Market Cap: US$15.2k

A biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States.

MPX International

Market Cap: US$14.4k

Operates as a cannabis company in Canada and internationally.

CardioGenics Holdings

Market Cap: US$14.3k

Engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally.

Allon Therapeutics

Market Cap: US$14.1k

A clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies.

HST Global

Market Cap: US$14.0k

Operates in the healthcare, software and media, and transportation industries.

NexImmune

Market Cap: US$13.9k

A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.

Acura Pharmaceuticals

Market Cap: US$13.3k

An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.

Pressure BioSciences

Market Cap: US$12.9k

Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.

Isodiol International

Market Cap: US$12.9k

Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.

Vaxxinity

Market Cap: US$12.7k

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

Scopus BioPharma

Market Cap: US$12.6k

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.

PaxMedica

Market Cap: US$12.6k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

NovAccess Global

Market Cap: US$12.4k

A biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States.

ObsEva

Market Cap: US$11.7k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.

Trevena

Market Cap: US$11.5k

A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.

Aridis Pharmaceuticals

Market Cap: US$10.7k

A late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections.

Healthtech Solutions

Market Cap: US$10.7k

Through its subsidiaries, operates as a life sciences company.

GeneLink

Market Cap: US$10.6k

Offers 12-gene DNA assessment services.

NuGenerex Immuno-Oncology

Market Cap: US$10.1k

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer.

Navidea Biopharmaceuticals

Market Cap: US$10.0k

A biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

Evelo Biosciences

Market Cap: US$9.5k

A clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects.